Analyst downgrades typically lead to a negative short-term impact on the stock price as they suggest a bearish outlook on the company's future performance. The substantial reduction in the price target from $37 to $24 by a reputable firm like Goldman Sachs could lead to a loss of investor confidence and a potential decrease in stock price.